Finance News – Ozempic
What is your interest today?
Tariffs
Ceo
Investors
Stock
Earnings
Stocks
Shares
Markets
China
Trade
Investment
Nasdaq
Revenue
Economy
Stock market
Wall street
Eqs
Warren buffett
Berkshire hathaway
Nvidia
Trade war
Prices
Inflation
Securities
Class action
Cet
Company
U.s.
Amazon
Apple
Guidance
Sales
S&p 500
Federal reserve
Bitcoin
Recession
Ipo
Tesla
Trading
Corporate
Crypto
Forecast
Microsoft
Companies
Shareholders
Interest rates
Gold
Walmart
Securities laws
Imports
Law firm
Financial reports
Salary
Inheritance
Plant
Travel
Annual meeting
Call options
Articles 117
Software chief
= 1024) { setSearchBy('title'); suggestionOpen = true; fetch() }"
@input.debounce.300ms="window.innerWidth >= 1024 && fetch()"
@keydown.enter.prevent="window.innerWidth >= 1024 && submitSearch()"
placeholder="Search finance news…"
class="flex-grow bg-transparent border-0 focus:ring-0
px-4 py-2 placeholder-gray-500 dark:placeholder-gray-400
text-gray-900 dark:text-gray-100 mr-2"
/>
Quartz • May 16, 2025
Novo Nordisk's CEO is out after the Ozempic maker's stock dropped 50% in a year
The departure of Novo Nordisk’s CEO follows a significant decline in the company’s share value, reflecting investor concerns amid challenges faced by its key diabetes and weight ma...
Read Full Article →
MarketWatch Top Stories • May 16, 2025
Ozempic maker Novo Nordisk boots CEO over stock-price fall
Novo Nordisk's decision to replace its CEO follows a decline in market value, reflecting investor concerns about the company's recent financial performance and future growth prospe...
Read Full Article →
Quartz • May 07, 2025
Weight Watchers goes bankrupt even as it tries to ride the Ozempic boom
WeightWatchers has filed for bankruptcy due to over $1 billion in debt, aiming to restructure its finances while shifting focus toward weight loss medications such as GLP-1 treatme...
Read Full Article →